In vivo conditioning of tissue-engineered heart muscle improves contractile performance

Artificial Organs

Volumn 29, Issue 11, 2005, Pages 866-875

  Birla, Ravi K ^b   Borschel, Gregory H ^b   Dennis, Robert G ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Angiogenesis; Cell culture; Contractile function; Epinephrine; Myocytes; Tissue engineering

Indexed keywords

CELL ENGINEERING; HEART; MUSCLE; TISSUE ENGINEERING;

ANGIOGENESIS; CARDIAC TISSUES; CONTRACTILE FUNCTION; EPINEPHRINE; HEART MUSCLES; IN-VITRO; IN-VIVO; MYOCYTES; TISSUE-ENGINEERED HEART; TISSUES ENGINEERINGS;

CELL CULTURE;

ADRENALIN; CALCIUM; EOSIN; HEMATOXYLIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CHRONOTROPISM; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXPLANT; FORCE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MODEL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT; TISSUE ENGINEERING; VASCULARIZATION; ANIMAL; ARTIFICIAL HEART PACEMAKER; BIOPROSTHESIS; CELL CULTURE; COMPARATIVE STUDY; CULTURE TECHNIQUE; FISCHER 344 RAT; HEART; HEART CONTRACTION; MECHANICAL STRESS; METHODOLOGY; MUSCLE CELL; PHYSIOLOGY; TRANSPLANTATION; ULTRASTRUCTURE;

CARDIOIDEA;

ANIMALS; BIOPROSTHESIS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; HEART; HEART, ARTIFICIAL; MUSCLE CELLS; MYOCARDIAL CONTRACTION; RATS; RATS, INBRED F344; STRESS, MECHANICAL; TISSUE ENGINEERING;

EID: 33644792942     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2005.00148.x     Document Type: Article

References (21)

1. 2002 Heart and Stroke Statistical Update, American Heart Association. 2002. Available at: http://www.americanheart.org.
2. Shimizu T, Yamato M, Kikuchi A, Okano T. Two-dimensional manipulation of cardiac myocyte sheets utilizing temperature-responsive culture dishes augments the pulsatile amplitude. Tissue Eng 2001 7 : 141 51.
3. Shimizu T, Yamato M, Akutsu T, et al. Electrically communicating three-dimensional cardiac tissue mimic fabricated by layered cultured cardiomyocyte sheets. J Biomed Mater Res 2002 60 : 110 7.
4. Shimizu T, Yamato M, Isoi Y, et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002 90 : e40.
5. Bursac N, Papadaki M, Cohen RJ, et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol 1999 277 : t 44.
6. Carrier RL, Papadaki M, Rupnick M, et al. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 1999 64 : 580 9.
7. Papadaki M, Bursac N, Langer R, Merok J, Vunjak-Novakovic G, Freed LE. Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol-Heart C 2001 280 : H168 78.
8. Li RK, Jia ZQ, Weisel RD, Mickle DA, Choi A, Yau TM. Survival and function of bioengineered cardiac grafts. Circulation 1999 100 (Suppl. 9.
9. Li RK, Yau TM, Weisel RD, et al. Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg 2000 119 : 368 75.
10. Sakai T, Li RK, Weisel RD, et al. The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. J Thorac Cardiovasc Surg 2001 121 : 932 42.
11. Leor J, Aboulafia-Etzion S, Dar A, et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 2000 102 (Suppl. 61.
12. Eschenhagen T, Fink C, Remmers U, et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 1997 11 : 683 94.
13. Souren JE, Schneijdenberg C, Verkleij AJ, Van Wijk R. Factors controlling the rhythmic contraction of collagen gels by neonatal heart cells. In Vitro Cell Dev B 1992 28A : t 204.
14. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 2000 68 : 106 14.
15. Zimmermann WH, Schneiderbanger K, Schubert P, et al. Tissue engineering of a differentiated cardiac muscle construct. [see comments.]. Circ Res 2002 90 : 223 30.
16. Baar K, Birla R, Boluyt MO, Borschel GH, Arruda EM, Dennis RG. Heart muscle by design: self-organization of rat cardiac cells into contractile 3-D cardiac tissue. FASEB J 2005 19 : 275 7.
17. Eschenhagen T, Didie M, Munzel F, Schubert P, Schneiderbanger K, Zimmermann WH. 3D engineered heart tissue for replacement therapy. Basic Res Cardiol 2002 97 (Suppl. 52.
18. Boluyt MO, Zheng JS, Younes A, et al. Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70, S6 kinase. Circ Res 1997 81 : 176 86.
19. Dennis RG, Kosnik PE, Gilbert ME, Faulkner JA. Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines. Am J Physiol-Cell Ph 2001 280 : C288 95.
20. Layland J, Young IS, Altringham JD. The effect of cycle frequency on the power output of rat papillary muscles in vitro. J Exp Biol 1995 198 : 1035 43.
21. Friedman WF. The intrinsic physiologic properties of the developing heart. Prog Cardiovasc Dis 1972 15 : 87 111.